Published :
Tables : 72
Figures : 48
Category : Healthcare
No. of Pages : 211
Report Code : HC-U3154
Type 2 Diabetes Market Overview The growth of the market can be attributed to the rise in the number of incidences of type-2 diabetes acros the world. According to the NCBI, over 85 million people were diagnosed with type-2 diabetes in 2014, which is anticipated to reach over 320 million cases by 2022. FutureWise Market Research has instantiated a report that provides an intricate analysis of the market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of the market. According to the research study conducted by FutureWise research analysts, the Type 2 Diabetes Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Type 2 Diabetes Market are: ELI LILLY AND CO. SANOFI AVENTIS A/S NOVO NORDISK MERCK & CO., INC. CHUGAI PHARMACEUTICAL CO. BRISTOL-MYERS SQUIBB PFIZER INC. BAYER AG GLAXOSMITHKLINE PLC. ASTRAZENECA PLC (Note: The list of the major players will be updated with the latest market scenario and trends) Type 2 Diabetes Market Segmentation: By Drug Class Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Thiazolidinediones Alpha-glucosidase Inhibitors Sulfonylureas & Other Insulin Secretagogues Biguanides SodiumGlucose Cotransporter 2 Inhibitors By Application Glycemic Control Cardiovascular Safety Hypoglycemia Avoidance Others By Region North America Latin America Europe Asia-Pacific Rest of the world Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting the market growth Objectives of the Study: To provide with an exhaustive analysis on the market By Drug Class, By Application and By Region. To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with the purchase of any license of the report You can directly share your requirements/changes to the current table of content to sales@futurewiseresearch.com
The growth of the market can be attributed to the rise in the number of incidences of type-2 diabetes acros the world. According to the NCBI, over 85 million people were diagnosed with type-2 diabetes in 2014, which is anticipated to reach over 320 million cases by 2022.
FutureWise Market Research has instantiated a report that provides an intricate analysis of the market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of the market.
According to the research study conducted by FutureWise research analysts, the Type 2 Diabetes Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Type 2 Diabetes Market are:
(Note: The list of the major players will be updated with the latest market scenario and trends)
Type 2 Diabetes Market Segmentation:
By Drug Class
By Application
By Region
Competitive Landscape:
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1 Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Type 2 Diabetes Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Type 2 Diabetes Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Biotech Companies Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of CNNs 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Type 2 Diabetes Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Type 2 Diabetes Market, By Drug Class Historical Analysis and Forecast 2020-2027 (USD Million) 7.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors 7.2 Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists 7.3 Thiazolidinediones 7.4 Alpha-glucosidase Inhibitors 7.5 Sulfonylureas & Other Insulin Secretagogues 7.6 Biguanides 7.7 SodiumGlucose Cotransporter 2 Inhibitors 8. Global Type 2 Diabetes Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million) 8.1 Glycemic Control 8.2 Cardiovascular Safety 8.3 Hypoglycemia Avoidance 8.4 Others 9. North America Type 2 Diabetes Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2020-2027 10. Latin America Type 2 Diabetes Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Regional Market Trends 10.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 10.3.1. Brazil 10.3.2. Venezuela 10.3.3. Argentina 10.3.4. Rest of Latin America 10.4. Market Size (USD Million) Forecast for Latin America 2020-2027 11. Europe Type 2 Diabetes Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Switzerland 11.2.9. Romania 11.2.10. Rest of Western Europe 11.3. Market Size (USD Million) Forecast for Europe 2020-2027 12. Asia Pacific Type 2 Diabetes Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Japan 12.2.2. China 12.2.3. Singapore 12.2.4. India 12.2.5. Australia and New Zealand 12.2.6. ASEAN 12.2.7. South Korea 12.2.8. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 13. Middle East and Africa Type 2 Diabetes Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Saudi Arabia 17.2.2. UAE 13.2.3. South Africa 13.2.4. Egypt 13.3. Market Size (USD Million) Forecast for MEA 2020-2027 14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 14.1 ELI LILLY AND CO. 14.1.1 Company Overview 14.1.2 Financial Overview 14.1.3 Strategic Overview 14.1.4 Product Portfolio 14.1.5 SWOT Analysis 14.2 SANOFI AVENTIS A/S 14.2.1 Company Overview 14.2.2 Financial Overview 14.2.3 Strategic Overview 14.2.4 Product Portfolio 14.2.5 SWOT Analysis 14.3 NOVO NORDISK 14.3.1 Company Overview 14.3.2 Financial Overview 14.3.3 Strategic Overview 14.3.4 Product Portfolio 14.3.5 SWOT Analysis 14.4. MERCK & CO., INC. 14.4.1 Company Overview 14.4.2 Financial Overview 14.4.3 Strategic Overview 14.4.4 Product Portfolio 14.4.5 SWOT Analysis 14.5. CHUGAI PHARMACEUTICAL CO. 14.5.1 Company Overview 14.5.2 Financial Overview 14.5.3 Strategic Overview 14.5.4 Product Portfolio 14.5.5 SWOT Analysis 14.6. BRISTOL-MYERS SQUIBB 14.6.1 Company Overview 14.6.2 Financial Overview 14.6.3 Strategic Overview 14.6.4 Product Portfolio 14.6.5 SWOT Analysis 14.7. PFIZER INC. 14.7.1 Company Overview 14.7.2 Financial Overview 14.7.3 Strategic Overview 14.7.4 Product Portfolio 14.7.5 SWOT Analysis 14.8. BAYER AG 14.8.1 Company Overview 14.8.2 Financial Overview 14.8.3 Strategic Overview 14.8.4 Product Portfolio 14.8.5 SWOT Analysis 14.9. GLAXOSMITHKLINE PLC. 14.9.1 Company Overview 14.9.2 Financial Overview 14.9.3 Strategic Overview 14.9.4 Product Portfolio 14.9.5 SWOT Analysis 14.10. ASTRAZENECA PLC 14.10.1 Company Overview 14.10.2 Financial Overview 14.10.3 Strategic Overview 14.10.4 Product Portfolio 14.10.5 SWOT Analysis 15. FutureWise SME key takeaway points for Client
1. Market Introduction
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Years Considered for the Study
1.3.2 Market Covered
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2. Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data from Primary Sources
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3. Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.3 Competitive Insights
4. Global Type 2 Diabetes Market Variables, Trends & Scope
4.1. Market Lineage Outlook
4.2. Penetration and Growth Prospect Mapping
4.3. Industry Value Chain Analysis
4.4. Cost Analysis Breakdown
4.5. Technology Overview
4.6. Regulatory Framework
4.6.1. Reimbursement Framework
4.6.2. Standards and Compliances
5. Global Type 2 Diabetes Market Overview
5.1. Market Dynamics
5.1.1. Market Driver Analysis
5.1.1.1. Increasing focus of Biotech Companies Brand Protection
5.1.1.2. Untapped Opportunities in Emerging Regions
5.1.2. Market Restraint Analysis
5.1.2.1. High Cost Associated with Implementation of CNNs
5.1.3. Industry Challenges
5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Type 2 Diabetes Market Analysis Tools
6.1. Industry Analysis - Porter’s
6.1.1. Supplier Power
6.1.2. Buyer Power
6.1.3. Substitution Threat
6.1.4. Threat from New Entrants
6.1.5. Competitive Rivalry
6.2. Pestel Analysis
6.2.1. Political Landscape
6.2.2. Environmental Landscape
6.2.3. Social Landscape
6.2.4. Technology Landscape
6.2.5. Legal Landscape
6.3. Major Deals And Strategic Alliances Analysis
6.3.1. Joint Ventures
6.3.2. Mergers and Acquisitions
6.3.3. Licensing and Partnership
6.3.4. Technology Collaborations
6.3.5. Strategic Divestments
6.4. Market Entry Strategies
6.5. Case Studies
7. Global Type 2 Diabetes Market, By Drug Class Historical Analysis and Forecast 2020-2027 (USD Million)
7.2 Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
7.3 Thiazolidinediones
7.4 Alpha-glucosidase Inhibitors
7.5 Sulfonylureas & Other Insulin Secretagogues
7.6 Biguanides
7.7 SodiumGlucose Cotransporter 2 Inhibitors
8. Global Type 2 Diabetes Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)
8.1 Glycemic Control
8.2 Cardiovascular Safety
8.3 Hypoglycemia Avoidance
8.4 Others
9. North America Type 2 Diabetes Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million
9.1. Introduction
9.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
9.2.1. U.S.A
9.2.2. Canada
9.2.3. Mexico
9.3. Market Size (USD Million) Forecast for North America 2020-2027
10. Latin America Type 2 Diabetes Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
10.1. Introduction
10.2. Regional Market Trends
10.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019
10.3.1. Brazil
10.3.2. Venezuela
10.3.3. Argentina
10.3.4. Rest of Latin America
10.4. Market Size (USD Million) Forecast for Latin America 2020-2027
11. Europe Type 2 Diabetes Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
11.1. Introduction
11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
11.2.1. Germany
11.2.2. U.K
11.2.3. France
11.2.4. Italy
11.2.5. Spain
11.2.6. Russia
11.2.7. Poland
11.2.8. Switzerland
11.2.9. Romania
11.2.10. Rest of Western Europe
11.3. Market Size (USD Million) Forecast for Europe 2020-2027
12. Asia Pacific Type 2 Diabetes Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
12.1. Introduction
12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
12.2.1. Japan
12.2.2. China
12.2.3. Singapore
12.2.4. India
12.2.5. Australia and New Zealand
12.2.6. ASEAN
12.2.7. South Korea
12.2.8. Rest of Asia Pacific
12.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
13. Middle East and Africa Type 2 Diabetes Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
13.1. Introduction
13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
13.2.1. Saudi Arabia
17.2.2. UAE
13.2.3. South Africa
13.2.4. Egypt
13.3. Market Size (USD Million) Forecast for MEA 2020-2027
14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
14.1 ELI LILLY AND CO.
14.1.1 Company Overview
14.1.2 Financial Overview
14.1.3 Strategic Overview
14.1.4 Product Portfolio
14.1.5 SWOT Analysis
14.2 SANOFI AVENTIS A/S
14.2.1 Company Overview
14.2.2 Financial Overview
14.2.3 Strategic Overview
14.2.4 Product Portfolio
14.2.5 SWOT Analysis
14.3 NOVO NORDISK
14.3.1 Company Overview
14.3.2 Financial Overview
14.3.3 Strategic Overview
14.3.4 Product Portfolio
14.3.5 SWOT Analysis
14.4. MERCK & CO., INC.
14.4.1 Company Overview
14.4.2 Financial Overview
14.4.3 Strategic Overview
14.4.4 Product Portfolio
14.4.5 SWOT Analysis
14.5. CHUGAI PHARMACEUTICAL CO.
14.5.1 Company Overview
14.5.2 Financial Overview
14.5.3 Strategic Overview
14.5.4 Product Portfolio
14.5.5 SWOT Analysis
14.6. BRISTOL-MYERS SQUIBB
14.6.1 Company Overview
14.6.2 Financial Overview
14.6.3 Strategic Overview
14.6.4 Product Portfolio
14.6.5 SWOT Analysis
14.7. PFIZER INC.
14.7.1 Company Overview
14.7.2 Financial Overview
14.7.3 Strategic Overview
14.7.4 Product Portfolio
14.7.5 SWOT Analysis
14.8. BAYER AG
14.8.1 Company Overview
14.8.2 Financial Overview
14.8.3 Strategic Overview
14.8.4 Product Portfolio
14.8.5 SWOT Analysis
14.9. GLAXOSMITHKLINE PLC.
14.9.1 Company Overview
14.9.2 Financial Overview
14.9.3 Strategic Overview
14.9.4 Product Portfolio
14.9.5 SWOT Analysis
14.10. ASTRAZENECA PLC
14.10.1 Company Overview
14.10.2 Financial Overview
14.10.3 Strategic Overview
14.10.4 Product Portfolio
14.10.5 SWOT Analysis
15. FutureWise SME key takeaway points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics